Mackenzie Financial Corp Invitae Corp Transaction History

Mackenzie Financial Corp

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Oct 07, 2022	BUY	$1.9 - $8.63 $2,762 - $12,548	1,454 Added 10.42%	15,402 $38,000
Q2 2022 Aug 10, 2022	BUY	$2.13 - $9.01 $5,953 - $25,182	2,795 Added 25.06%	13,948 $34,000
Q1 2022 May 13, 2022	BUY	$6.28 - $15.59 $979 - $2,432	156 Added 1.42%	11,153 $89,000
Q4 2021 Feb 14, 2022	SELL	$14.7 - $28.67 $2,895 - $5,647	-197 Reduced 1.76%	10,997 $168,000
Q3 2021 Nov 08, 2021	BUY	$24.31 - $33.6 $117,903 - $162,960	4,850 Added 76.45%	11,194 $318,000
Q2 2021 Aug 11, 2021	BUY	$26.09 - $40.4 $165,514 - $256,297	6,344 New	6,344 $214,000
Q3 2019 Nov 14, 2019	SELL	$18.85 - $27.5 $291,232 - $424,875	-15,450 Closed	0 $0
Q2 2019 Aug 14, 2019	BUY	$17.37 - $26.27 $268,366 - $405,871	15,450 New	15,450 $363,000

2.12M

Ticker NVTA
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 235,266,000
Description
Invitae Corporation, a medical genetics company, integrates genetic information into mainstream medicine to improve healthcare of people in the United States, Canada, and internationally. The company offers genetic tests in various clinical areas, including hereditary cancer, cardiology, neurology, pediatrics, oncology, metabolic conditions, and...

Get notified when there are updates to the investment portfolio of Mackenzie Financial Corp, based on Form 13F filings with the SEC.

Stay updated on Mackenzie Financial Corp with notifications on news.